Larvol Delta - Bold-Therapeutics39-ClinicalStage-Anticancer-Agent-BOLD100-Demonstrates-Neuroprotective-Potential-when-Utilized-in-Combination-with-FOLFOX-for-the-Treatment-of-Advanced-Gastrointestinal-Cancers

BOLD-100 - Bold Therap

https://www.prnewswire.com/news-releases/bold-therapeutics-clinical-stage-anticancer-agent-bold-100-demonstrates-neuroprotective-potential-when-utilized-in-combination-with-folfox-for-the-treatment-of-advanced-gastrointestinal-cancers-302783987.html

May 28, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next